Answers are grounded in this paper and cite their sources.
Clinical and biological characterization of MPN patients harboring two driver mutations, a French intergroup of myeloproliferative
No takes yet. Share an insight, caveat, or question.
Mansier et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: